IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,910,247 | +63.0% | 1,707,394 | +152.0% | 0.01% | +66.7% |
Q3 2022 | $6,694,000 | +74.4% | 677,579 | +194.9% | 0.00% | +50.0% |
Q1 2022 | $3,839,000 | +52.9% | 229,734 | +78.0% | 0.00% | +100.0% |
Q4 2021 | $2,510,000 | -29.3% | 129,063 | -3.7% | 0.00% | -50.0% |
Q2 2021 | $3,550,000 | +2529.6% | 134,046 | +3021.0% | 0.00% | – |
Q1 2021 | $135,000 | -20.1% | 4,295 | +30.1% | 0.00% | – |
Q4 2020 | $169,000 | +207.3% | 3,301 | +69.5% | 0.00% | – |
Q3 2020 | $55,000 | -6.8% | 1,948 | +0.8% | 0.00% | – |
Q2 2020 | $59,000 | -75.4% | 1,933 | -76.7% | 0.00% | – |
Q1 2020 | $240,000 | -44.4% | 8,313 | -46.8% | 0.00% | – |
Q4 2019 | $432,000 | +92.0% | 15,632 | +26.1% | 0.00% | – |
Q3 2019 | $225,000 | -23.2% | 12,394 | +3.8% | 0.00% | – |
Q2 2019 | $293,000 | +1231.8% | 11,937 | +410.6% | 0.00% | – |
Q1 2019 | $22,000 | -33.3% | 2,338 | -39.0% | 0.00% | – |
Q4 2018 | $33,000 | +3.1% | 3,833 | +31.9% | 0.00% | – |
Q3 2018 | $32,000 | -36.0% | 2,905 | -25.9% | 0.00% | – |
Q2 2018 | $50,000 | -10.7% | 3,922 | +17.5% | 0.00% | – |
Q1 2018 | $56,000 | +700.0% | 3,338 | +298.3% | 0.00% | – |
Q4 2017 | $7,000 | -36.4% | 838 | -38.5% | 0.00% | – |
Q3 2017 | $11,000 | +83.3% | 1,363 | +62.6% | 0.00% | – |
Q2 2017 | $6,000 | – | 838 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |